Novel NTRK3 Fusions in Fibrosarcomas of Adults
2019
NTRK fusions in malignant tumors are therapeutic targets of tyrosine kinase inhibitors. Because they occur only in a small subset of mesenchymal tumors, knowledge regarding the corresponding histology is important to effectively identify patients who could benefit from targeted therapy. In this stud
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
37
References
28
Citations
NaN
KQI